Lipoproteins and Cardiovascular Health
Most cited papers
- Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative UltracentrifugeClinical Chemistry · 1972 · 32,392 citations
- Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)JAMA · 1993 · 27,955 citations
- Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control studyThe Lancet · 2004 · 12,388 citations
- Diagnosis and Management of the Metabolic SyndromeCirculation · 2005 · 12,143 citations
- Prediction of Coronary Heart Disease Using Risk Factor CategoriesCirculation · 1998 · 9,658 citations
- Enzymatic Determination of Total Serum CholesterolClinical Chemistry · 1974 · 9,170 citations
- THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUMJournal of Clinical Investigation · 1955 · 8,755 citations
- General Cardiovascular Risk Profile for Use in Primary CareCirculation · 2008 · 7,745 citations
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine · 1995 · 7,689 citations
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine · 1996 · 7,419 citations
- Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III GuidelinesCirculation · 2004 · 6,868 citations
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive ProteinNew England Journal of Medicine · 2008 · 6,784 citations
- Prevalence of the Metabolic Syndrome Among US AdultsJAMA · 2002 · 6,739 citations
- Markers of Inflammation and Cardiovascular DiseaseCirculation · 2003 · 6,553 citations
- Beyond CholesterolNew England Journal of Medicine · 1989 · 6,453 citations
- 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice GuidelinesCirculation · 2019 · 6,429 citations
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular DiseaseNew England Journal of Medicine · 2017 · 6,357 citations
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA · 1998 · 6,205 citations
- C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in WomenNew England Journal of Medicine · 2000 · 5,911 citations
- Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy MenNew England Journal of Medicine · 1997 · 5,493 citations
- Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE projectEuropean Heart Journal · 2003 · 5,367 citations
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine · 1998 · 5,267 citations
- Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol LevelsJAMA · 1998 · 5,228 citations
- Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary SyndromesNew England Journal of Medicine · 2004 · 4,966 citations
- 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice GuidelinesCirculation · 2019 · 4,613 citations
- Ezetimibe Added to Statin Therapy after Acute Coronary SyndromesNew England Journal of Medicine · 2015 · 4,600 citations
- Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus PanelEuropean Heart Journal · 2017 · 4,216 citations
- Cardiovascular Risk Reduction with Icosapent Ethyl for HypertriglyceridemiaNew England Journal of Medicine · 2018 · 3,463 citations
- Homocysteine and cardiovascular disease: evidence on causality from a meta-analysisBMJ · 2002 · 1,951 citations
- Plasma Homocysteine as a Risk Factor for Vascular DiseaseJAMA · 1997 · 1,816 citations
- Trans Fatty Acids and Cardiovascular DiseaseNew England Journal of Medicine · 2006 · 1,804 citations
- Plasma Homocysteine Levels and Mortality in Patients with Coronary Artery DiseaseNew England Journal of Medicine · 1997 · 1,754 citations
- Homocysteine Lowering with Folic Acid and B Vitamins in Vascular DiseaseNew England Journal of Medicine · 2006 · 1,740 citations
- A Prospective Study of Plasma Homocyst(e)ine and Risk of Myocardial Infarction in US PhysiciansJAMA · 1992 · 1,695 citations
- Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials.Arteriosclerosis and Thrombosis A Journal of Vascular Biology · 1992 · 1,485 citations
- Dietary Fats and Cardiovascular Disease: A Presidential Advisory From the American Heart AssociationCirculation · 2017 · 1,483 citations
- Homocysteine Lowering and Cardiovascular Events after Acute Myocardial InfarctionNew England Journal of Medicine · 2006 · 1,452 citations
- Effect of Dietary trans Fatty Acids on High-Density and Low-Density Lipoprotein Cholesterol Levels in Healthy SubjectsNew England Journal of Medicine · 1990 · 1,433 citations
- Comparison of effects of dietary saturated, monounsaturated, and polyunsaturated fatty acids on plasma lipids and lipoproteins in man.Journal of Lipid Research · 1985 · 1,353 citations
- Effects on Coronary Heart Disease of Increasing Polyunsaturated Fat in Place of Saturated Fat: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsPLoS Medicine · 2010 · 1,249 citations
- Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular RiskJAMA · 2020 · 1,083 citations
- Total Plasma Homocysteine and Cardiovascular Risk ProfileJAMA · 1995 · 1,077 citations
- Effect of Dietary Stearic Acid on Plasma Cholesterol and Lipoprotein LevelsNew England Journal of Medicine · 1988 · 913 citations
- Reduction of Plasma Lipids, Lipoproteins, and Apoproteins by Dietary Fish Oils in Patients with HypertriglyceridemiaNew England Journal of Medicine · 1985 · 848 citations
Metadata from OpenAlex (CC0).